Novo Nordisk (NVO) reports Q4 earnings with expectations of 86 cents EPS and $11.40B revenues. Stock down 29.55% YOY, 4.81% YTD. Analysts see 68% upside.
Novo Nordisk Stock Slides Before Q4 Earnings: Analysts Still See 68% Upside
Where Today's News Shapes Tomorrow
